The U.S. FDA has released new guidance for medical devices aimed at weight loss, laying out stricter requirements for clinical trials, effectiveness, and safety.
BrightGene has reported positive Phase 1 results for BGM0504, an oral obesity drug. The treatment is designed to work like GLP-1 therapies – but without injections.
OpenAI has announced it will shut down Sora, its AI video generation app. The company hasn’t shared a full timeline yet, but says both the app and its API will be discontinued.
The Ukrainian military has begun testing exoskeletons designed to help soldiers carry heavy equipment. The systems are meant to support tasks like artillery work, where troops handle dozens of heavy shells every day.